GSA Capital Partners’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $699K | Buy |
+224,629
| New | +$699K | 0.05% | 691 |
|
|
2025
Q1 | – | Sell |
-123,459
| Closed | -$700K | – | 2112 |
|
|
2024
Q4 | $700K | Buy |
+123,459
| New | +$700K | 0.05% | 656 |
|
|
2021
Q4 | – | Sell |
-234,981
| Closed | -$618K | – | 1837 |
|
|
2021
Q3 | $618K | Sell |
234,981
-11,023
| -4% | -$29K | 0.06% | 566 |
|
|
2021
Q2 | $1.02M | Buy |
246,004
+180,058
| +273% | +$744K | 0.11% | 246 |
|
|
2021
Q1 | $311K | Buy |
+65,946
| New | +$311K | 0.05% | 626 |
|
|
2020
Q2 | – | Sell |
-14,425
| Closed | -$132K | – | 1144 |
|
|
2020
Q1 | $132K | Sell |
14,425
-34,399
| -70% | -$315K | 0.03% | 851 |
|
|
2019
Q4 | $681K | Buy |
48,824
+24,094
| +97% | +$336K | 0.08% | 447 |
|
|
2019
Q3 | $426K | Buy |
+24,730
| New | +$426K | 0.06% | 653 |
|
|
2019
Q2 | – | Sell |
-19,178
| Closed | -$367K | – | 1757 |
|
|
2019
Q1 | $367K | Sell |
19,178
-15,022
| -44% | -$287K | 0.04% | 877 |
|
|
2018
Q4 | $321K | Buy |
+34,200
| New | +$321K | 0.04% | 798 |
|
|
2018
Q3 | – | Sell |
-30,400
| Closed | -$594K | – | 1927 |
|
|
2018
Q2 | $594K | Buy |
+30,400
| New | +$594K | 0.03% | 1072 |
|